Inside the AI-Driven mRNA Cancer Vaccine Revolution | Sid Sijbrandij on GitLab + Biotech
06 Oct 2026AI processed
Sid Sijbrandij, co-founder of GitLab, applies "founder mode" to his battle with rare bone cancer, challenging the limitations of standard clinical trials that prioritize data collection over patient outcomes. By adopting a parallel treatment strategy, he combines experimental modalities like personalized mRNA vaccines,...